US FDA requests removal of suicide warnings from weight-loss drugs – CNN

US FDA requests removal of suicide warnings from weight-loss drugs  CNN FDA calls on GLP-1 drugmakers to remove suicide warnings  Axios FDA Wants Suicide Warning Removed From Weight-Loss Drugs  Bloomberg.com Novo Nordisk (NVO) and Eli Lilly (LLY) to Update Drug Labels Fol  GuruFocus Eli Lilly stock (LLY) edges up as FDA clears GLP-1 label cloud; $150 pill launch looms  TechStock²

How Weight Loss Pills Could Reshape The GLP-1 Landscape

Injectable GLP-1s for obesity have been revolutionary products of the pharmaceutical industry over the past few years. Now, for the first time, the weight loss drug is being offered in pill form. Novo Nordisk’s Wegovy pill hit the market on January 5th and rival Eli Lilly has its own version currently waiting for FDA approval. […]

Hims GLP1

Simplify weight loss into something more manageable with Hims’s personalized care. Visit Uncrate for the full post.

FDA requests removal of suicide warnings from weight-loss drugs – CNBC

FDA requests removal of suicide warnings from weight-loss drugs  CNBC US FDA requests removal of suicide warnings from weight-loss drugs  CNN FDA calls on GLP-1 drugmakers to remove suicide warnings  Axios US FDA requests removal of suicide warnings from weight-loss drug labels  Reuters FDA Wants Suicide Warning Removed From Weight-Loss Drugs  Bloomberg.com

New human clinical data puts botanicals into the GLP-1 spotlight

California-based Gateway Health Alliances (GHA) has unveiled new human clinical data showing that two botanical extracts known for their metabolic health benefits boost the activity of “satiety hormone” GLP-1. Dyglomera (a standardized extract of African spice fruit D. glomerata) and CQR-300 (a standardized extract of the succulent Cissus quadrangularis) have been shown in other human […]